Pharma Stability: Insights, Guidelines, and Expertise
Biologics, including monoclonal antibodies, vaccines, and recombinant proteins, are highly sensitive to environmental contaminants such as oxygen, moisture, and microbes. CCI failures can lead to:
Click to read the full article.
Unlike small-molecule drugs, biologics—such as monoclonal antibodies, peptides, and fusion proteins—are macromolecules with complex structures. They are prone to degradation via aggregation, denaturation, oxidation, and adsorption. Packaging systems must:
Click to read the full article.
Multi-dose vials (MDVs) contain sufficient volume for multiple doses, typically preserved to prevent microbial growth after multiple punctures. Common in vaccines, hormone therapies, and monoclonal antibodies, these vials require robust formulation and packaging strategies to ensure product quality throughout the intended in-use period.
Click to read the full article.
Microbiological stability refers to a product’s ability to remain free from microbial contamination over its intended shelf life and during in-use conditions. It ensures that:
Click to read the full article.
A combination product comprises two or more regulated components—typically a drug (biologic) and a device—physically, chemically, or otherwise combined to be used together. Common examples in the biopharma space include:
Click to read the full article.
Accelerated stability testing involves storing drug substances or products at stress conditions above their recommended storage temperatures—commonly 25°C/60% RH or 40°C/75% RH—for a shorter duration. The primary objectives are to:
Click to read the full article.
Real-time stability testing involves storing a biologic product under its recommended long-term storage conditions (e.g., 2–8°C or 25°C/60% RH) and periodically analyzing its critical quality attributes over the proposed shelf life.
Click to read the full article.
In-use stability testing refers to the evaluation of a drug product’s stability after its immediate container is opened, its seal is punctured, or its contents are reconstituted, diluted, or transferred prior to administration.
Click to read the full article.
Lyophilization removes water under low temperature and pressure, converting a biologic formulation into a dry, solid cake. The process helps to:
Click to read the full article.
After reconstitution, biologic molecules—such as monoclonal antibodies, enzymes, and cytokines—are more prone to chemical, physical, and microbiological degradation. Factors affecting stability include:
Click to read the full article.